{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:56:03Z","timestamp":1793339763298,"version":"4.5.0"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The advent of high-throughput single-cell transcriptomic analysis of microglia has revealed different phenotypes that are inherently associated with disease conditions. A common feature of some of these activated phenotypes is the upregulation of galectin-3. Representative examples of these phenotypes include disease-associated microglia (DAM) and white-associated microglia (WAM), whose role(s) in neuroprotection\/neurotoxicity is a matter of high interest in the microglia community. In this review, we summarise the main findings that demonstrate the ability of galectin-3 to interact with key pattern recognition receptors, including, among others, TLR4 and TREM2 and the importance of galectin-3 in the regulation of microglia activation. Finally, we discuss increasing evidence supporting the involvement of this lectin in the main neurodegenerative diseases, including Alzheimer\u2019s disease, Parkinson\u2019s disease, Huntington\u2019s disease, amyotrophic lateral sclerosis, multiple sclerosis, traumatic brain injury, and stroke.<\/jats:p>","DOI":"10.1038\/s41419-022-05058-3","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T07:06:35Z","timestamp":1658300795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2160-5813","authenticated-orcid":false,"given":"Juan","family":"Garc\u00eda-Revilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Boza-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Espinosa-Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Sarmiento","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Deierborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5142-9972","authenticated-orcid":false,"given":"Roc\u00edo","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo M.","family":"de Pablos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3165-9997","authenticated-orcid":false,"given":"Miguel Angel","family":"Burguillos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1137-8706","authenticated-orcid":false,"given":"Jose L.","family":"Venero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"key":"5058_CR1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/WCO.0000000000000812","volume":"33","author":"F Barake","year":"2020","unstructured":"Barake F, Soza A, Gonz\u00e1lez A. Galectins in the brain: advances in neuroinflammation, neuroprotection and therapeutic opportunities. Curr Opin Neurol. 2020;33:381\u201390.","journal-title":"Curr Opin Neurol"},{"key":"5058_CR2","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s00018-019-03327-7","volume":"77","author":"CGHM de Jong","year":"2020","unstructured":"de Jong CGHM, Gabius HJ, Baron W. The emerging role of galectins in (re)myelination and its potential for developing new approaches to treat multiple sclerosis. Cell Mol Life Sci. 2020;77:1289\u2013317.","journal-title":"Cell Mol Life Sci"},{"key":"5058_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/0092-8674(94)90498-7","volume":"76","author":"SH Barondes","year":"1994","unstructured":"Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T, et al. Galectins: a family of animal beta-galactoside-binding lectins. Cell. 1994;76:597\u20138.","journal-title":"Cell"},{"key":"5058_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrc1527","volume":"5","author":"FT Liu","year":"2005","unstructured":"Liu FT, Rabinovich GA. Galectins as modulators of tumour progression. Nat Rev Cancer. 2005;5:29\u201341.","journal-title":"Nat Rev Cancer"},{"key":"5058_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.molmed.2018.02.008","volume":"24","author":"MA Toscano","year":"2018","unstructured":"Toscano MA, Mart\u00ednez Allo VC, Cutine AM, Rabinovich GA, Mari\u00f1o KV. Untangling GAlectin-driven Regulatory Circuits in Autoimmune Inflammation. Trends Mol Med. 2018;24:348\u201363.","journal-title":"Trends Mol Med"},{"key":"5058_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fnmol.2018.00158","volume":"11","author":"JJ Siew","year":"2018","unstructured":"Siew JJ, Chern Y. Microglial lectins in health and neurological diseases. Front Mol Neurosci. 2018;11:158.","journal-title":"Front Mol Neurosci"},{"key":"5058_CR7","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169:1276\u201390.e1217.","journal-title":"Cell"},{"key":"5058_CR8","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47:566\u201381.e569.","journal-title":"Immunity"},{"key":"5058_CR9","doi-asserted-by":"publisher","first-page":"e101997","DOI":"10.15252\/embj.2019101997","volume":"38","author":"V Stratoulias","year":"2019","unstructured":"Stratoulias V, Venero JL, Tremblay M, Joseph B. Microglial subtypes: diversity within the microglial community. EMBO J. 2019;38:e101997.","journal-title":"EMBO J"},{"key":"5058_CR10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nn.4338","volume":"19","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. A polarising question: do M1 and M2 microglia exist? Nat Neurosci. 2016;19:987\u201391.","journal-title":"Nat Neurosci"},{"key":"5058_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40478-015-0203-5","volume":"3","author":"IR Holtman","year":"2015","unstructured":"Holtman IR, Raj DD, Miller JA, Schaafsma W, Yin Z, Brouwer N, et al. Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis. Acta Neuropathol Commun. 2015;3:31.","journal-title":"Acta Neuropathol Commun"},{"key":"5058_CR12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.celrep.2017.09.039","volume":"21","author":"H Mathys","year":"2017","unstructured":"Mathys H, Adaikkan C, Gao F, Young JZ, Manet E, Hemberg M, et al. Temporal tracking of microglia activation in neurodegeneration at single-cell resolution. Cell Rep. 2017;21:366\u201380.","journal-title":"Cell Rep."},{"key":"5058_CR13","doi-asserted-by":"crossref","unstructured":"Boza-Serrano A, Ruiz R, Sanchez-Varo R, Garc\u00eda-Revilla J, Yang Y, Jimenez-Ferrer I, et al. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer\u2019s disease. Acta Neuropathol. 2019;138:251\u201373.","DOI":"10.1007\/s00401-019-02013-z"},{"key":"5058_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep41689","volume":"7","author":"PK Yip","year":"2017","unstructured":"Yip PK, Carrillo-Jimenez A, King P, Vilalta A, Nomura K, Chau CC, et al. Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegeneration. Sci Rep. 2017;7:41689.","journal-title":"Sci Rep."},{"key":"5058_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13024-018-0254-8","volume":"13","author":"S Rangaraju","year":"2018","unstructured":"Rangaraju S, Dammer EB, Raza SA, Rathakrishnan P, Xiao H, Gao T, et al. Identification and therapeutic modulation of a proinflammatory subset of disease-associated-microglia in Alzheimer\u2019s disease. Mol Neurodegener. 2018;13:24.","journal-title":"Mol Neurodegener"},{"key":"5058_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s40478-020-01037-x","volume":"8","author":"M Huang","year":"2020","unstructured":"Huang M, Modeste E, Dammer E, Merino P, Taylor G, Duong DM, et al. Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations. Acta Neuropathol Commun. 2020;8:163.","journal-title":"Acta Neuropathol Commun"},{"key":"5058_CR17","doi-asserted-by":"crossref","unstructured":"Zhang J, Velmeshev D, Hashimoto K, Huang YH, Hofmann JW, Shi X, et al. Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency. Nature. 2020;588:459\u201365.","DOI":"10.1038\/s41586-020-2709-7"},{"key":"5058_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1146\/annurev-pathmechdis-012418-012955","volume":"14","author":"JW Hofmann","year":"2019","unstructured":"Hofmann JW, Seeley WW, Huang EJ. RNA binding proteins and the pathogenesis of frontotemporal lobar degeneration. Annu Rev Pathol. 2019;14:469\u201395.","journal-title":"Annu Rev Pathol"},{"key":"5058_CR19","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell. 2015;160:1061\u201371.","journal-title":"Cell"},{"key":"5058_CR20","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1172\/JCI77983","volume":"125","author":"PL Poliani","year":"2015","unstructured":"Poliani PL, Wang Y, Fontana E, Robinette ML, Yamanishi Y, Gilfillan S, et al. TREM2 sustains microglial expansion during aging and response to demyelination. J Clin Invest. 2015;125:2161\u201370.","journal-title":"J Clin Invest"},{"key":"5058_CR21","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41593-020-0650-6","volume":"23","author":"BJ Andreone","year":"2020","unstructured":"Andreone BJ, Przybyla L, Llapashtica C, Rana A, Davis SS, van Lengerich B, et al. Alzheimer\u2019s-associated PLC\u03b32 is a signaling node required for both TREM2 function and the inflammatory response in human microglia. Nat Neurosci. 2020;23:927\u201338.","journal-title":"Nat Neurosci"},{"key":"5058_CR22","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.bbrc.2005.10.033","volume":"338","author":"P Lukyanov","year":"2005","unstructured":"Lukyanov P, Furtak V, Ochieng J. Galectin-3 interacts with membrane lipids and penetrates the lipid bilayer. Biochem Biophys Res Commun. 2005;338:1031\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"5058_CR23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","volume":"105","author":"AA Nugent","year":"2020","unstructured":"Nugent AA, Lin K, van Lengerich B, Lianoglou S, Przybyla L, Davis SS, et al. TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge. Neuron. 2020;105:837\u201354.e839.","journal-title":"Neuron"},{"key":"5058_CR24","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.neuron.2021.01.027","volume":"109","author":"S Safaiyan","year":"2021","unstructured":"Safaiyan S, Besson-Girard S, Kaya T, Cantuti-Castelvetri L, Liu L, Ji H, et al. White matter aging drives microglial diversity. Neuron. 2021;109:1100\u201317.e1110.","journal-title":"Neuron"},{"key":"5058_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","volume":"50","author":"TR Hammond","year":"2019","unstructured":"Hammond TR, Dufort C, Dissing-Olesen L, Giera S, Young A, Wysoker A, et al. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity. 2019;50:253\u201371.e256.","journal-title":"Immunity"},{"key":"5058_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuron.2018.12.006","volume":"101","author":"Q Li","year":"2019","unstructured":"Li Q, Cheng Z, Zhou L, Darmanis S, Neff NF, Okamoto J, et al. Developmental heterogeneity of microglia and brain myeloid cells revealed by deep single-cell RNA sequencing. Neuron. 2019;101:207\u201323.e210.","journal-title":"Neuron"},{"key":"5058_CR27","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-G\u00f3mez JA, Kavanagh E, Engskog-Vlachos P, Engskog MKR, Herrera AJ, Espinosa-Oliva AM, et al. Microglia: Agents of the CNS pro-inflammatory response. Cells. 2020;9:1717.","DOI":"10.3390\/cells9071717"},{"key":"5058_CR28","doi-asserted-by":"publisher","first-page":"7254","DOI":"10.4049\/jimmunol.181.10.7254","volume":"181","author":"M Jana","year":"2008","unstructured":"Jana M, Palencia CA, Pahan K. Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer\u2019s disease. J Immunol. 2008;181:7254\u201362.","journal-title":"J Immunol"},{"key":"5058_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2534","volume":"4","author":"C Kim","year":"2013","unstructured":"Kim C, Ho DH, Suk JE, You S, Michael S, Kang J, et al. Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun. 2013;4:1562.","journal-title":"Nat Commun"},{"key":"5058_CR30","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1016\/j.pain.2014.06.007","volume":"155","author":"NM Agalave","year":"2014","unstructured":"Agalave NM, Larsson M, Abdelmoaty S, Su J, Baharpoor A, Lundb\u00e4ck P, et al. Spinal HMGB1 induces TLR4-mediated long-lasting hypersensitivity and glial activation and regulates pain-like behavior in experimental arthritis. Pain. 2014;155:1802\u201313.","journal-title":"Pain"},{"key":"5058_CR31","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.celrep.2015.02.012","volume":"10","author":"MA Burguillos","year":"2015","unstructured":"Burguillos MA, Svensson M, Schulte T, Boza-Serrano A, Garcia-Quintanilla A, Kavanagh E, et al. Microglia-secreted galectin-3 acts as a toll-like receptor 4 ligand and contributes to microglial activation. Cell Rep. 2015;10:1626\u201338.","journal-title":"Cell Rep."},{"key":"5058_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-5-23","volume":"5","author":"JJ Jin","year":"2008","unstructured":"Jin JJ, Kim HD, Maxwell JA, Li L, Fukuchi K. Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer\u2019s disease. J Neuroinflammation. 2008;5:23.","journal-title":"J Neuroinflammation"},{"key":"5058_CR33","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1074\/jbc.M110.135244","volume":"286","author":"I Maezawa","year":"2011","unstructured":"Maezawa I, Zimin PI, Wulff H, Jin LW. Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity. J Biol Chem. 2011;286:3693\u2013706.","journal-title":"J Biol Chem"},{"key":"5058_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s42003-020-0792-9","volume":"3","author":"C Hughes","year":"2020","unstructured":"Hughes C, Choi ML, Yi JH, Kim SC, Drews A, George-Hyslop PS, et al. Beta amyloid aggregates induce sensitised TLR4 signalling causing long-term potentiation deficit and rat neuronal cell death. Commun Biol. 2020;3:79.","journal-title":"Commun Biol"},{"key":"5058_CR35","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.1007\/s12035-019-1540-3","volume":"56","author":"M Herrera-Rivero","year":"2019","unstructured":"Herrera-Rivero M, Santarelli F, Brosseron F, Kummer MP, Heneka MT. Dysregulation of TLR5 and TAM ligands in the Alzheimer\u2019s brain as contributors to disease progression. Mol Neurobiol. 2019;56:6539\u201350.","journal-title":"Mol Neurobiol"},{"key":"5058_CR36","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.4049\/jimmunol.177.7.4679","volume":"177","author":"T Jouault","year":"2006","unstructured":"Jouault T, El Abed-El Behi M, Mart\u00ednez-Esparza M, Breuilh L, Trinel PA, Chamaillard M, et al. Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J Immunol. 2006;177:4679\u201387.","journal-title":"J Immunol"},{"key":"5058_CR37","doi-asserted-by":"publisher","first-page":"32744","DOI":"10.1074\/jbc.M110.137588","volume":"285","author":"F Debierre-Grockiego","year":"2010","unstructured":"Debierre-Grockiego F, Niehus S, Coddeville B, Elass E, Poirier F, Weingart R, et al. Binding of Toxoplasma gondii glycosylphosphatidylinositols to galectin-3 is required for their recognition by macrophages. J Biol Chem. 2010;285:32744\u201350.","journal-title":"J Biol Chem"},{"key":"5058_CR38","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.1158\/0008-5472.CAN-04-1816","volume":"64","author":"T Shimura","year":"2004","unstructured":"Shimura T, Takenaka Y, Tsutsumi S, Hogan V, Kikuchi A, Raz A. Galectin-3, a novel binding partner of beta-catenin. Cancer Res. 2004;64:6363\u20137.","journal-title":"Cancer Res"},{"key":"5058_CR39","doi-asserted-by":"publisher","first-page":"7037","DOI":"10.4049\/jimmunol.1000154","volume":"185","author":"SB Jeon","year":"2010","unstructured":"Jeon SB, Yoon HJ, Chang CY, Koh HS, Jeon SH, Park EJ. Galectin-3 exerts cytokine-like regulatory actions through the JAK-STAT pathway. J Immunol. 2010;185:7037\u201346.","journal-title":"J Immunol"},{"key":"5058_CR40","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.4049\/jimmunol.180.4.2650","volume":"180","author":"AC MacKinnon","year":"2008","unstructured":"MacKinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, Leffler H, et al. Regulation of alternative macrophage activation by galectin-3. J Immunol. 2008;180:2650\u20138.","journal-title":"J Immunol"},{"key":"5058_CR41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cyto.2015.01.016","volume":"73","author":"U Arad","year":"2015","unstructured":"Arad U, Madar-Balakirski N, Angel-Korman A, Amir S, Tzadok S, Segal O, et al. Galectin-3 is a sensor-regulator of toll-like receptor pathways in synovial fibroblasts. Cytokine. 2015;73:30\u20135.","journal-title":"Cytokine"},{"key":"5058_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cellimm.2015.01.017","volume":"294","author":"SS Chen","year":"2015","unstructured":"Chen SS, Sun LW, Brickner H, Sun PQ. Downregulating galectin-3 inhibits proinflammatory cytokine production by human monocyte-derived dendritic cells via RNA interference. Cell Immunol. 2015;294:44\u201353.","journal-title":"Cell Immunol"},{"key":"5058_CR43","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.7150\/thno.33959","volume":"9","author":"V Volarevic","year":"2019","unstructured":"Volarevic V, Markovic BS, Jankovic MG, Djokovic B, Jovicic N, Harrell CR, et al. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1\/Kynurenine pathway in renal DCs. Theranostics. 2019;9:5976\u20136001.","journal-title":"Theranostics"},{"key":"5058_CR44","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jneuroim.2019.03.012","volume":"332","author":"V Kumar","year":"2019","unstructured":"Kumar V. Toll-like receptors in the pathogenesis of neuroinflammation. J Neuroimmunol. 2019;332:16\u201330.","journal-title":"J Neuroimmunol"},{"key":"5058_CR45","doi-asserted-by":"crossref","unstructured":"Wu ZS, Lo JJ, Wu SH, Wang CZ, Chen RF, Lee SS, et al. Early hyperbaric oxygen treatment attenuates burn-induced neuroinflammation by inhibiting the galectin-3-dependent toll-like receptor-4 pathway in a rat model. Int J Mol Sci. 2018;19:2195.","DOI":"10.3390\/ijms19082195"},{"key":"5058_CR46","doi-asserted-by":"publisher","first-page":"10383","DOI":"10.1523\/JNEUROSCI.1498-12.2012","volume":"32","author":"M Lalancette-H\u00e9bert","year":"2012","unstructured":"Lalancette-H\u00e9bert M, Swarup V, Beaulieu JM, Bohacek I, Abdelhamid E, Weng YC, et al. Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury. J Neurosci. 2012;32:10383\u201395.","journal-title":"J Neurosci"},{"key":"5058_CR47","doi-asserted-by":"crossref","unstructured":"Huang Y, Happonen KE, Burrola PG, O\u2019Connor C, Hah N, Huang L, et al. Microglia use TAM receptors to detect and engulf amyloid \u03b2 plaques. Nat Immunol. 2021;22:586\u201394.","DOI":"10.1038\/s41590-021-00913-5"},{"key":"5058_CR48","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.4049\/jimmunol.1502532","volume":"198","author":"K Nomura","year":"2017","unstructured":"Nomura K, Vilalta A, Allendorf DH, Hornik TC, Brown GC. Activated microglia desialylate and phagocytose cells via neuraminidase, galectin-3, and mer tyrosine kinase. J Immunol. 2017;198:4792\u2013801.","journal-title":"J Immunol"},{"key":"5058_CR49","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/jcp.22955","volume":"227","author":"NB Caberoy","year":"2012","unstructured":"Caberoy NB, Alvarado G, Bigcas JL, Li W. Galectin-3 is a new MerTK-specific eat-me signal. J Cell Physiol. 2012;227:401\u20137.","journal-title":"J Cell Physiol"},{"key":"5058_CR50","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.3389\/fimmu.2019.02647","volume":"10","author":"TOJ Cockram","year":"2019","unstructured":"Cockram TOJ, Puigdell\u00edvol M, Brown GC. Calreticulin and galectin-3 opsonise bacteria for phagocytosis by microglia. Front Immunol. 2019;10:2647.","journal-title":"Front Immunol"},{"key":"5058_CR51","doi-asserted-by":"publisher","first-page":"577496","DOI":"10.1016\/j.jneuroim.2021.577496","volume":"353","author":"TJ Wenzel","year":"2021","unstructured":"Wenzel TJ, Ranger AL, McRae SA, Klegeris A. Extracellular cardiolipin modulates microglial phagocytosis and cytokine secretion in a toll-like receptor (TLR) 4-dependent manner. J Neuroimmunol. 2021;353:577496.","journal-title":"J Neuroimmunol"},{"key":"5058_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1209-2","volume":"15","author":"C Diesselberg","year":"2018","unstructured":"Diesselberg C, Ribes S, Seele J, Kaufmann A, Redlich S, Bunkowski S, et al. Activin A increases phagocytosis of Escherichia coli K1 by primary murine microglial cells activated by toll-like receptor agonists. J Neuroinflammation. 2018;15:175.","journal-title":"J Neuroinflammation"},{"key":"5058_CR53","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/glia.22693","volume":"62","author":"JJ Neher","year":"2014","unstructured":"Neher JJ, Neniskyte U, Hornik T, Brown GC. Inhibition of UDP\/P2Y6 purinergic signaling prevents phagocytosis of viable neurons by activated microglia in vitro and in vivo. Glia. 2014;62:1463\u201375.","journal-title":"Glia"},{"key":"5058_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15119-w","volume":"11","author":"I Choi","year":"2020","unstructured":"Choi I, Zhang Y, Seegobin SP, Pruvost M, Wang Q, Purtell K, et al. Microglia clear neuron-released \u03b1-synuclein via selective autophagy and prevent neurodegeneration. Nat Commun. 2020;11:1386.","journal-title":"Nat Commun"},{"key":"5058_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1281-7","volume":"15","author":"A Rubio-Araiz","year":"2018","unstructured":"Rubio-Araiz A, Finucane OM, Keogh S, Lynch MA. Anti-TLR2 antibody triggers oxidative phosphorylation in microglia and increases phagocytosis of \u03b2-amyloid. J Neuroinflammation. 2018;15:247.","journal-title":"J Neuroinflammation"},{"key":"5058_CR56","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/15548627.2018.1556946","volume":"15","author":"JW Lee","year":"2019","unstructured":"Lee JW, Nam H, Kim LE, Jeon Y, Min H, Ha S, et al. TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia. Autophagy. 2019;15:753\u201370.","journal-title":"Autophagy"},{"key":"5058_CR57","doi-asserted-by":"crossref","unstructured":"Grubman A, Choo XY, Chew G, Ouyang JF, Sun G, Croft NP, et al. Transcriptional signature in microglia associated with A\u03b2 plaque phagocytosis. Nat Commun. 2021;12:3015.","DOI":"10.1038\/s41467-021-23111-1"},{"key":"5058_CR58","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14:388\u2013405.","journal-title":"Lancet Neurol"},{"key":"5058_CR59","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3233\/JAD-160912","volume":"55","author":"AN Nilson","year":"2017","unstructured":"Nilson AN, English KC, Gerson JE, Barton Whittle T, Nicolas Crain C, Xue J, et al. Tau oligomers associate with inflammation in the brain and retina of tauopathy mice and in neurodegenerative diseases. J Alzheimers Dis. 2017;55:1083\u201399.","journal-title":"J Alzheimers Dis"},{"key":"5058_CR60","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2016.04.200","volume":"100","author":"F Yin","year":"2016","unstructured":"Yin F, Sancheti H, Patil I, Cadenas E. Energy metabolism and inflammation in brain aging and Alzheimer\u2019s disease. Free Radic Biol Med. 2016;100:108\u201322.","journal-title":"Free Radic Biol Med"},{"key":"5058_CR61","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1126\/science.aay0793","volume":"366","author":"A Nott","year":"2019","unstructured":"Nott A, Holtman IR, Coufal NG, Schlachetzki JCM, Yu M, Hu R, et al. Brain cell type-specific enhancer-promoter interactome maps and disease. Science. 2019;366:1134\u20139.","journal-title":"Science"},{"key":"5058_CR62","doi-asserted-by":"crossref","unstructured":"Burguillos MA, Svensson M, Schulte T, Boza-Serrano A, Garcia-Quintanilla A, Kavanagh E, et al. Microglia-secreted galectin-3 acts as a toll-like receptor 4 ligand and contributes to microglial activation. Cell Rep. 2015;10:1626\u201338.","DOI":"10.1016\/j.celrep.2015.02.012"},{"key":"5058_CR63","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, et al. Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020;26:769\u201380.","journal-title":"Nat Med"},{"key":"5058_CR64","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20160844","volume":"214","author":"L Zhong","year":"2017","unstructured":"Zhong L, Chen XF, Wang T, Wang Z, Liao C, Huang R, et al. Soluble TREM2 induces inflammatory responses and enhances microglial survival. J Exp Med. 2017;214:597\u2013607.","journal-title":"J Exp Med"},{"key":"5058_CR65","doi-asserted-by":"publisher","first-page":"466","DOI":"10.15252\/emmm.201506123","volume":"8","author":"M Su\u00e1rez-Calvet","year":"2016","unstructured":"Su\u00e1rez-Calvet M, Kleinberger G, Araque Caballero M, Brendel M, Rominger A, Alcolea D, et al. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer\u2019s disease and associate with neuronal injury markers. EMBO Mol Med. 2016;8:466\u201376.","journal-title":"EMBO Mol Med"},{"key":"5058_CR66","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016;90:724\u201339.","journal-title":"Neuron"},{"key":"5058_CR67","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.neuron.2018.02.002","volume":"97","author":"CYD Lee","year":"2018","unstructured":"Lee CYD, Daggett A, Gu X, Jiang LL, Langfelder P, Li X, et al. Elevated TREM2 gene dosage reprograms microglia responsivity and ameliorates pathological phenotypes in Alzheimer\u2019s disease models. Neuron. 2018;97:1032\u201348.e1035.","journal-title":"Neuron"},{"key":"5058_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19699-y","volume":"8","author":"A Boza-Serrano","year":"2018","unstructured":"Boza-Serrano A, Yang Y, Paulus A, Deierborg T. Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer\u2019s disease mouse model 5xFAD. Sci Rep. 2018;8:1550.","journal-title":"Sci Rep."},{"key":"5058_CR69","doi-asserted-by":"crossref","unstructured":"Sebastian Monasor L, M\u00fcller SA, Colombo AV, Tanrioever G, K\u00f6nig J, Roth S, et al. Fibrillar A\u03b2 triggers microglial proteome alterations and dysfunction in Alzheimer mouse models. Elife. 2020;9:e54083.","DOI":"10.7554\/eLife.54083"},{"key":"5058_CR70","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1177\/1533317513495107","volume":"30","author":"X Wang","year":"2015","unstructured":"Wang X, Zhang S, Lin F, Chu W, Yue S. Elevated galectin-3 levels in the serum of patients with Alzheimer\u2019s disease. Am J Alzheimers Dis Other Demen. 2015;30:729\u201332.","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"5058_CR71","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s13760-020-01477-1","volume":"121","author":"T Yazar","year":"2021","unstructured":"Yazar T, Olgun Yazar H, Cihan M. Evaluation of serum galectin-3 levels at Alzheimer patients by stages: a preliminary report. Acta Neurol Belg. 2021;121:949\u201354.","journal-title":"Acta Neurol Belg"},{"key":"5058_CR72","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/jdi.13256","volume":"11","author":"S Ma","year":"2020","unstructured":"Ma S, Li S, Lv R, Hou X, Nie S, Yin Q. Prevalence of mild cognitive impairment in type 2 diabetes mellitus is associated with serum galectin-3 level. J Diabetes Investig. 2020;11:1295\u2013302.","journal-title":"J Diabetes Investig"},{"key":"5058_CR73","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1002\/pmic.201200190","volume":"13","author":"L Ijsselstijn","year":"2013","unstructured":"Ijsselstijn L, Papma JM, Dekker LJ, Calame W, Stingl C, Koudstaal PJ, et al. Serum proteomics in amnestic mild cognitive impairment. Proteomics. 2013;13:2526\u201333.","journal-title":"Proteomics"},{"key":"5058_CR74","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11357-017-9965-y","volume":"39","author":"E Shobin","year":"2017","unstructured":"Shobin E, Bowley MP, Estrada LI, Heyworth NC, Orczykowski ME, Eldridge SA, et al. Microglia activation and phagocytosis: relationship with aging and cognitive impairment in the rhesus monkey. Geroscience. 2017;39:199\u2013220.","journal-title":"Geroscience"},{"key":"5058_CR75","doi-asserted-by":"publisher","first-page":"8878412","DOI":"10.1155\/2020\/8878412","volume":"2020","author":"H Lim","year":"2020","unstructured":"Lim H, Lee D, Choi WK, Choi SJ, Oh W, Kim DH. Galectin-3 secreted by human umbilical cord blood-derived mesenchymal stem cells reduces aberrant tau phosphorylation in an alzheimer disease model. Stem Cells Int. 2020;2020:8878412.","journal-title":"Stem Cells Int"},{"key":"5058_CR76","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s40478-40014-40156-40470","volume":"2","author":"A Boza-Serrano","year":"2015","unstructured":"Boza-Serrano A, Reyes JF, Rey NL, Leffler H, Bousset L, Nilsson U, et al. The role of Galectin-3 in alpha-synuclein-induced microglial activation. Acta Neuropathol Commun. 2015;2:156. https:\/\/doi.org\/10.1186\/s40478-40014-40156-40470","journal-title":"Acta Neuropathol Commun"},{"key":"5058_CR77","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.3389\/fimmu.2020.02069","volume":"11","author":"J Garcia-Revilla","year":"2020","unstructured":"Garcia-Revilla J, Deierborg T, Venero JL, Boza-Serrano A. Hyperinflammation and fibrosis in severe COVID-19 patients: galectin-3, a target molecule to consider. Front Immunol. 2020;11:2069.","journal-title":"Front Immunol"},{"key":"5058_CR78","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jocn.2019.08.032","volume":"70","author":"HO Yazar","year":"2019","unstructured":"Yazar HO, Yazar T, Cihan M. A preliminary data: Evaluation of serum galectin-3 levels in patients with Idiopathic Parkinson\u2019s disease. J Clin Neurosci. 2019;70:164\u20138.","journal-title":"J Clin Neurosci"},{"key":"5058_CR79","doi-asserted-by":"publisher","first-page":"105373","DOI":"10.1016\/j.clineuro.2019.105373","volume":"184","author":"T Cengiz","year":"2019","unstructured":"Cengiz T, T\u00fcrkboylar\u0131 S, Gen\u00e7ler OS, Anlar \u00d6. The roles of galectin-3 and galectin-4 in the idiopatic Parkinson disease and its progression. Clin Neurol Neurosurg. 2019;184:105373.","journal-title":"Clin Neurol Neurosurg"},{"key":"5058_CR80","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3389\/fncel.2018.00398","volume":"12","author":"I Garc\u00eda-Dom\u00ednguez","year":"2018","unstructured":"Garc\u00eda-Dom\u00ednguez I, Vesel\u00e1 K, Garc\u00eda-Revilla J, Carrillo-Jim\u00e9nez A, Roca-Ceballos MA, Santiago M, et al. Peripheral inflammation enhances microglia response and nigral dopaminergic cell death in an in vivo MPTP model of Parkinson's disease. Front Cell Neurosci. 2018;12:398.","journal-title":"Front Cell Neurosci"},{"key":"5058_CR81","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2017.01.010","volume":"53","author":"S Belloli","year":"2017","unstructured":"Belloli S, Pannese M, Buonsanti C, Maiorino C, Di Grigoli G, Carpinelli A, et al. Early upregulation of 18-kDa translocator protein in response to acute neurodegenerative damage in TREM2-deficient mice. Neurobiol Aging. 2017;53:159\u201368.","journal-title":"Neurobiol Aging"},{"key":"5058_CR82","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00401-017-1722-x","volume":"134","author":"WP Flavin","year":"2017","unstructured":"Flavin WP, Bousset L, Green ZC, Chu Y, Skarpathiotis S, Chaney MJ, et al. Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins. Acta Neuropathol. 2017;134:629\u201353.","journal-title":"Acta Neuropathol"},{"key":"5058_CR83","doi-asserted-by":"publisher","first-page":"e104494","DOI":"10.15252\/embj.2020104494","volume":"39","author":"S Herbst","year":"2020","unstructured":"Herbst S, Campbell P, Harvey J, Bernard EM, Papayannopoulos V, Wood NW, et al. LRRK2 activation controls the repair of damaged endomembranes in macrophages. EMBO J. 2020;39:e104494.","journal-title":"EMBO J"},{"key":"5058_CR84","first-page":"1497","volume":"25","author":"GP Kishchenko","year":"1991","unstructured":"Kishchenko GP, Minenkova OO, Il\u2019ichev AI, Gruzdev AD, Petrenko VA. Structure of virions of the M13 phage containing chimeric B-protein molecules. Mol Biol. 1991;25:1497\u2013503.","journal-title":"Mol Biol"},{"key":"5058_CR85","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian SH, Lewis AJ, Genoud C, Hench J, Moors TE, Navarro PP, et al. Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat Neurosci. 2019;22:1099\u2013109.","journal-title":"Nat Neurosci"},{"key":"5058_CR86","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes.","year":"1993","unstructured":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell. 1993;72:971\u201383.","journal-title":"Cell"},{"key":"5058_CR87","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1083\/jcb.200508072","volume":"171","author":"JY Shin","year":"2005","unstructured":"Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol. 2005;171:1001\u201312.","journal-title":"J Cell Biol"},{"key":"5058_CR88","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nn.3668","volume":"17","author":"A Crotti","year":"2014","unstructured":"Crotti A, Benner C, Kerman BE, Gosselin D, Lagier-Tourenne C, Zuccato C, et al. Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors. Nat Neurosci. 2014;17:513\u201321.","journal-title":"Nat Neurosci"},{"key":"5058_CR89","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1093\/hmg\/ddu151","volume":"23","author":"HY Hsiao","year":"2014","unstructured":"Hsiao HY, Chiu FL, Chen CM, Wu YR, Chen HM, Chen YC, et al. Inhibition of soluble tumor necrosis factor is therapeutic in Huntington\u2019s disease. Hum Mol Genet. 2014;23:4328\u201344.","journal-title":"Hum Mol Genet"},{"key":"5058_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11441-0","volume":"10","author":"JJ Siew","year":"2019","unstructured":"Siew JJ, Chen HM, Chen HY, Chen HL, Chen CM, Soong BW, et al. Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington\u2019s disease. Nat Commun. 2019;10:3473.","journal-title":"Nat Commun"},{"key":"5058_CR91","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1093\/brain\/awaa309","volume":"143","author":"BE Clarke","year":"2020","unstructured":"Clarke BE, Patani R. The microglial component of amyotrophic lateral sclerosis. Brain. 2020;143:3526\u201339.","journal-title":"Brain"},{"key":"5058_CR92","doi-asserted-by":"publisher","first-page":"104870","DOI":"10.1016\/j.nbd.2020.104870","volume":"140","author":"E Abati","year":"2020","unstructured":"Abati E, Citterio G, Bresolin N, Comi GP, Corti S. Glial cells involvement in spinal muscular atrophy: could SMA be a neuroinflammatory disease? Neurobiol Dis. 2020;140:104870.","journal-title":"Neurobiol Dis"},{"key":"5058_CR93","doi-asserted-by":"publisher","first-page":"9201","DOI":"10.1523\/JNEUROSCI.1470-07.2007","volume":"27","author":"L Ferraiuolo","year":"2007","unstructured":"Ferraiuolo L, Heath PR, Holden H, Kasher P, Kirby J, Shaw PJ. Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. J Neurosci. 2007;27:9201\u201319.","journal-title":"J Neurosci"},{"key":"5058_CR94","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1089\/ars.2012.4524","volume":"17","author":"D Capitanio","year":"2012","unstructured":"Capitanio D, Vasso M, Ratti A, Grignaschi G, Volta M, Moriggi M, et al. Molecular signatures of amyotrophic lateral sclerosis disease progression in hind and forelimb muscles of an SOD1(G93A) mouse model. Antioxid Redox Signal. 2012;17:1333\u201350.","journal-title":"Antioxid Redox Signal"},{"key":"5058_CR95","doi-asserted-by":"publisher","first-page":"5133","DOI":"10.1021\/pr100409r","volume":"9","author":"JY Zhou","year":"2010","unstructured":"Zhou JY, Afjehi-Sadat L, Asress S, Duong DM, Cudkowicz M, Glass JD, et al. Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach. J Proteome Res. 2010;9:5133\u201341.","journal-title":"J Proteome Res"},{"key":"5058_CR96","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nn.2297","volume":"12","author":"S Saxena","year":"2009","unstructured":"Saxena S, Cabuy E, Caroni P. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci. 2009;12:627\u201336.","journal-title":"Nat Neurosci"},{"key":"5058_CR97","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/NEN.0b013e31822581ac","volume":"70","author":"M Hossaini","year":"2011","unstructured":"Hossaini M, Cardona Cano S, van Dis V, Haasdijk ED, Hoogenraad CC, Holstege JC, et al. Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice. J Neuropathol Exp Neurol. 2011;70:662\u201377.","journal-title":"J Neuropathol Exp Neurol"},{"key":"5058_CR98","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/brb3.75","volume":"2","author":"BJ Lerman","year":"2012","unstructured":"Lerman BJ, Hoffman EP, Sutherland ML, Bouri K, Hsu DK, Liu FT, et al. Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Brain Behav. 2012;2:563\u201375.","journal-title":"Brain Behav"},{"key":"5058_CR99","doi-asserted-by":"publisher","first-page":"7759","DOI":"10.1523\/JNEUROSCI.1748-18.2020","volume":"40","author":"\u00c9 Martineau","year":"2020","unstructured":"Martineau \u00c9, Arbour D, Vall\u00e9e J, Robitaille R. Properties of glial cell at the neuromuscular junction are incompatible with synaptic repairin the SOD1G37R ALS mouse model. J Neurosci. 2020;40:7759\u201377.","journal-title":"J Neurosci"},{"key":"5058_CR100","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.devcel.2019.10.025","volume":"52","author":"J Jia","year":"2020","unstructured":"Jia J, Claude-Taupin A, Gu Y, Choi SW, Peters R, Bissa B, et al. Galectin-3 coordinates a cellular system for lysosomal repair and removal. Dev Cell. 2020;52:69\u201387.e68.","journal-title":"Dev Cell"},{"key":"5058_CR101","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372:1502\u201317.","journal-title":"Lancet"},{"key":"5058_CR102","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev.neuro.051508.135600","volume":"32","author":"A Kriegstein","year":"2009","unstructured":"Kriegstein A, Alvarez-Buylla A. The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci. 2009;32:149\u201384.","journal-title":"Annu Rev Neurosci"},{"key":"5058_CR103","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrn917","volume":"3","author":"RJ Franklin","year":"2002","unstructured":"Franklin RJ. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci. 2002;3:705\u201314.","journal-title":"Nat Rev Neurosci"},{"key":"5058_CR104","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nrn.2017.136","volume":"18","author":"RJM Franklin","year":"2017","unstructured":"Franklin RJM, Ffrench-Constant C. Regenerating CNS myelin - from mechanisms to experimental medicines. Nat Rev Neurosci. 2017;18:753\u201369.","journal-title":"Nat Rev Neurosci"},{"key":"5058_CR105","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s12035-018-1089-6","volume":"56","author":"L Thomas","year":"2019","unstructured":"Thomas L, Pasquini LA. Extracellular galectin-3 induces accelerated oligodendroglial differentiation through changes in signaling pathways and cytoskeleton dynamics. Mol Neurobiol. 2019;56:336\u201349.","journal-title":"Mol Neurobiol"},{"key":"5058_CR106","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fncel.2018.00297","volume":"12","author":"L Thomas","year":"2018","unstructured":"Thomas L, Pasquini LA. Galectin-3-mediated glial crosstalk drives oligodendrocyte differentiation and (re)myelination. Front Cell Neurosci. 2018;12:297.","journal-title":"Front Cell Neurosci"},{"key":"5058_CR107","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s12035-019-01787-3","volume":"57","author":"L Thomas","year":"2020","unstructured":"Thomas L, Pasquini LA. Galectin-3 exerts a pro-differentiating and pro-myelinating effect within a temporal window spanning precursors and pre-oligodendrocytes: insights into the mechanisms of action. Mol Neurobiol. 2020;57:976\u201387.","journal-title":"Mol Neurobiol"},{"key":"5058_CR108","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1365-2990.2011.01184.x","volume":"37","author":"M Stancic","year":"2011","unstructured":"Stancic M, van Horssen J, Thijssen VL, Gabius HJ, van der Valk P, Hoekstra D, et al. Increased expression of distinct galectins in multiple sclerosis lesions. Neuropathol Appl Neurobiol. 2011;37:654\u201371.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"5058_CR109","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1177\/1352458516655217","volume":"23","author":"H Nishihara","year":"2017","unstructured":"Nishihara H, Shimizu F, Kitagawa T, Yamanaka N, Akada J, Kuramitsu Y, et al. Identification of galectin-3 as a possible antibody target for secondary progressive multiple sclerosis. Mult Scler. 2017;23:382\u201394.","journal-title":"Mult Scler"},{"key":"5058_CR110","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1177\/1352458515573094","volume":"21","author":"JD Haines","year":"2015","unstructured":"Haines JD, Vidaurre OG, Zhang F, Riffo-Campos \u00c1, Castillo J, Casanova B, et al. Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors. Mult Scler. 2015;21:1655\u201369.","journal-title":"Mult Scler"},{"key":"5058_CR111","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.4049\/jimmunol.182.2.1167","volume":"182","author":"HR Jiang","year":"2009","unstructured":"Jiang HR, Al Rasebi Z, Mensah-Brown E, Shahin A, Xu D, Goodyear CS, et al. Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis. J Immunol. 2009;182:1167\u201373.","journal-title":"J Immunol"},{"key":"5058_CR112","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.neuint.2018.06.007","volume":"118","author":"T Itabashi","year":"2018","unstructured":"Itabashi T, Arima Y, Kamimura D, Higuchi K, Bando Y, Takahashi-Iwanaga H, et al. Cell- and stage-specific localisation of galectin-3, a \u03b2-galactoside-binding lectin, in a mouse model of experimental autoimmune encephalomyelitis. Neurochem Int. 2018;118:176\u201384.","journal-title":"Neurochem Int"},{"key":"5058_CR113","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/glia.22906","volume":"64","author":"RE James","year":"2016","unstructured":"James RE, Hillis J, Adorj\u00e1n I, Gration B, Mundim MV, Iqbal AJ, et al. Loss of galectin-3 decreases the number of immune cells in the subventricular zone and restores proliferation in a viral model of multiple sclerosis. Glia. 2016;64:105\u201321.","journal-title":"Glia"},{"key":"5058_CR114","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0165-5728(02)00205-9","volume":"130","author":"EJ McMahon","year":"2002","unstructured":"McMahon EJ, Suzuki K, Matsushima GK. Peripheral macrophage recruitment in cuprizone-induced CNS demyelination despite an intact blood-brain barrier. J Neuroimmunol. 2002;130:32\u201345.","journal-title":"J Neuroimmunol"},{"key":"5058_CR115","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1084\/jem.20141656","volume":"212","author":"A Lampron","year":"2015","unstructured":"Lampron A, Larochelle A, Laflamme N, Pr\u00e9fontaine P, Plante MM, S\u00e1nchez MG, et al. Inefficient clearance of myelin debris by microglia impairs remyelinating processes. J Exp Med. 2015;212:481\u201395.","journal-title":"J Exp Med"},{"key":"5058_CR116","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/978-3-319-40764-7_15","volume":"949","author":"HC Hoyos","year":"2016","unstructured":"Hoyos HC, Marder M, Ulrich R, Gudi V, Stangel M, Rabinovich GA, et al. The role of galectin-3: from oligodendroglial differentiation and myelination to demyelination and remyelination processes in a cuprizone-induced demyelination model. Adv Exp Med Biol. 2016;949:311\u201332.","journal-title":"Adv Exp Med Biol"},{"key":"5058_CR117","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.nbd.2013.10.023","volume":"62","author":"HC Hoyos","year":"2014","unstructured":"Hoyos HC, Rinaldi M, Mendez-Huergo SP, Marder M, Rabinovich GA, Pasquini JM, et al. Galectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination. Neurobiol Dis. 2014;62:441\u201355.","journal-title":"Neurobiol Dis"},{"key":"5058_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0651-2","volume":"13","author":"JM Hillis","year":"2016","unstructured":"Hillis JM, Davies J, Mundim MV, Al-Dalahmah O, Szele FG. Cuprizone demyelination induces a unique inflammatory response in the subventricular zone. J Neuroinflammation. 2016;13:190.","journal-title":"J Neuroinflammation"},{"key":"5058_CR119","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.exer.2010.11.009","volume":"92","author":"P Arg\u00fceso","year":"2011","unstructured":"Arg\u00fceso P, Panjwani N. Focus on molecules: galectin-3. Exp Eye Res. 2011;92:2\u20133.","journal-title":"Exp Eye Res"},{"key":"5058_CR120","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.neurobiolaging.2014.12.024","volume":"36","author":"N Pearce","year":"2015","unstructured":"Pearce N, Gallo V, McElvenny D. Head trauma in sport and neurodegenerative disease: an issue whose time has come? Neurobiol Aging. 2015;36:1383\u20139.","journal-title":"Neurobiol Aging"},{"key":"5058_CR121","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13049-015-0133-z","volume":"23","author":"A Brazinova","year":"2015","unstructured":"Brazinova A, Majdan M, Leitgeb J, Trimmel H, Mauritz W. Care AWGoIoET. Factors that may improve outcomes of early traumatic brain injury care: prospective multicenter study in Austria. Scand J Trauma Resusc Emerg Med. 2015;23:53.","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"5058_CR122","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.brainres.2012.07.058","volume":"1475","author":"A Pajoohesh-Ganji","year":"2012","unstructured":"Pajoohesh-Ganji A, Knoblach SM, Faden AI, Byrnes KR. Characterisation of inflammatory gene expression and galectin-3 function after spinal cord injury in mice. Brain Res. 2012;1475:96\u2013105.","journal-title":"Brain Res"},{"key":"5058_CR123","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.expneurol.2015.07.006","volume":"271","author":"K Mostacada","year":"2015","unstructured":"Mostacada K, Oliveira FL, Villa-Verde DM, Martinez AM. Lack of galectin-3 improves the functional outcome and tissue sparing by modulating inflammatory response after a compressive spinal cord injury. Exp Neurol. 2015;271:390\u2013400.","journal-title":"Exp Neurol"},{"key":"5058_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-130","volume":"8","author":"KR Byrnes","year":"2011","unstructured":"Byrnes KR, Washington PM, Knoblach SM, Hoffman E, Faden AI. Delayed inflammatory mRNA and protein expression after spinal cord injury. J Neuroinflammation. 2011;8:130.","journal-title":"J Neuroinflammation"},{"key":"5058_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-7-32","volume":"7","author":"C Venkatesan","year":"2010","unstructured":"Venkatesan C, Chrzaszcz M, Choi N, Wainwright MS. Chronic upregulation of activated microglia immunoreactive for galectin-3\/Mac-2 and nerve growth factor following diffuse axonal injury. J Neuroinflammation. 2010;7:32.","journal-title":"J Neuroinflammation"},{"key":"5058_CR126","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1089\/089771503770195777","volume":"20","author":"JE Natale","year":"2003","unstructured":"Natale JE, Ahmed F, Cernak I, Stoica B, Faden AI. Gene expression profile changes are commonly modulated across models and species after traumatic brain injury. J Neurotrauma. 2003;20:907\u201327.","journal-title":"J Neurotrauma"},{"key":"5058_CR127","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cca.2016.02.029","volume":"456","author":"YF Shen","year":"2016","unstructured":"Shen YF, Yu WH, Dong XQ, Du Q, Yang DB, Wu GQ, et al. The change of plasma galectin-3 concentrations after traumatic brain injury. Clin Chim Acta. 2016;456:75\u201380.","journal-title":"Clin Chim Acta"},{"key":"5058_CR128","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/neu.2014.3811","volume":"33","author":"R Shan","year":"2016","unstructured":"Shan R, Szmydynger-Chodobska J, Warren OU, Mohammad F, Zink BJ, Chodobski A. A new panel of blood biomarkers for the diagnosis of mild traumatic brain injury\/concussion in adults. J Neurotrauma. 2016;33:49\u201357.","journal-title":"J Neurotrauma"},{"key":"5058_CR129","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5607\/en.2014.23.2.138","volume":"23","author":"JH Hayward","year":"2014","unstructured":"Hayward JH, Lee SJ. A decade of research on TLR2 discovering its pivotal role in glial activation and neuroinflammation in neurodegenerative diseases. Exp Neurobiol. 2014;23:138\u201347.","journal-title":"Exp Neurobiol"},{"key":"5058_CR130","doi-asserted-by":"publisher","first-page":"e57208","DOI":"10.1371\/journal.pone.0057208","volume":"8","author":"A Ahmad","year":"2013","unstructured":"Ahmad A, Crupi R, Campolo M, Genovese T, Esposito E, Cuzzocrea S. Absence of TLR4 reduces neurovascular unit and secondary inflammatory process after traumatic brain injury in mice. PLoS ONE. 2013;8:e57208.","journal-title":"PLoS ONE"},{"key":"5058_CR131","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s40478-016-0365-9","volume":"4","author":"J Rodhe","year":"2016","unstructured":"Rodhe J, Burguillos MA, de Pablos RM, Kavanagh E, Persson A, Englund E, et al. Spatio-temporal activation of caspase-8 in myeloid cells upon ischemic stroke. Acta Neuropathol Commun. 2016;4:92.","journal-title":"Acta Neuropathol Commun"},{"key":"5058_CR132","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fncel.2019.00157","volume":"13","author":"F Bonsack","year":"2019","unstructured":"Bonsack F, Sukumari-Ramesh S. Differential cellular expression of galectin-1 and galectin-3 after intracerebral hemorrhage. Front Cell Neurosci. 2019;13:157.","journal-title":"Front Cell Neurosci"},{"key":"5058_CR133","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.brainres.2009.06.073","volume":"1288","author":"YP Yan","year":"2009","unstructured":"Yan YP, Lang BT, Vemuganti R, Dempsey RJ. Galectin-3 mediates post-ischemic tissue remodeling. Brain Res. 2009;1288:116\u201324.","journal-title":"Brain Res"},{"key":"5058_CR134","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1007\/s12035-019-1527-0","volume":"56","author":"R Rahimian","year":"2019","unstructured":"Rahimian R, Lively S, Abdelhamid E, Lalancette-Hebert M, Schlichter L, Sato S, et al. Delayed galectin-3-mediated reprogramming of microglia after stroke is protective. Mol Neurobiol. 2019;56:6371\u201385.","journal-title":"Mol Neurobiol"},{"key":"5058_CR135","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.brainres.2011.01.049","volume":"1382","author":"K Satoh","year":"2011","unstructured":"Satoh K, Niwa M, Goda W, Binh NH, Nakashima M, Takamatsu M, et al. Galectin-3 expression in delayed neuronal death of hippocampal CA1 following transient forebrain ischemia, and its inhibition by hypothermia. Brain Res. 2011;1382:266\u201374.","journal-title":"Brain Res"},{"key":"5058_CR136","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.bbi.2016.11.005","volume":"60","author":"S Chip","year":"2017","unstructured":"Chip S, Fern\u00e1ndez-L\u00f3pez D, Li F, Faustino J, Derugin N, Vexler ZS. Genetic deletion of galectin-3 enhances neuroinflammation, affects microglial activation and contributes to sub-chronic injury in experimental neonatal focal stroke. Brain Behav Immun. 2017;60:270\u201381.","journal-title":"Brain Behav Immun"},{"key":"5058_CR137","doi-asserted-by":"publisher","first-page":"109752","DOI":"10.18632\/oncotarget.18211","volume":"8","author":"H Dong","year":"2017","unstructured":"Dong H, Wang ZH, Zhang N, Liu SD, Zhao JJ, Liu SY. Serum galectin-3 level, not galectin-1, is associated with the clinical feature and outcome in patients with acute ischemic stroke. Oncotarget. 2017;8:109752\u201361.","journal-title":"Oncotarget"},{"key":"5058_CR138","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.nbd.2009.12.024","volume":"38","author":"C Doverhag","year":"2010","unstructured":"Doverhag C, Hedtj\u00e4rn M, Poirier F, Mallard C, Hagberg H, Karlsson A, et al. Galectin-3 contributes to neonatal hypoxic\u2013ischemic brain injury. Neurobiol Dis. 2010;38:36\u201346.","journal-title":"Neurobiol Dis"},{"key":"5058_CR139","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.nbd.2013.11.003","volume":"63","author":"CC Young","year":"2014","unstructured":"Young CC, Al-Dalahmah O, Lewis NJ, Brooks KJ, Jenkins MM, Poirier F, et al. Blocked angiogenesis in Galectin-3 null mice does not alter cellular and behavioral recovery after middle cerebral artery occlusion stroke. Neurobiol Dis. 2014;63:155\u201364.","journal-title":"Neurobiol Dis"},{"key":"5058_CR140","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1177\/0271678X20931137","volume":"41","author":"UV Wesley","year":"2021","unstructured":"Wesley UV, Sutton IC, Cunningham K, Jaeger JW, Phan AQ, Hatcher JF, et al. Galectin-3 protects against ischemic stroke by promoting neuro-angiogenesis via apoptosis inhibition and Akt\/Caspase regulation. J Cereb Blood Flow Metab. 2021;41:857\u201373.","journal-title":"J Cereb Blood Flow Metab"},{"key":"5058_CR141","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.drudis.2017.11.004","volume":"23","author":"R Rahimian","year":"2018","unstructured":"Rahimian R, B\u00e9land LC, Kriz J. Galectin-3: mediator of microglia responses in injured brain. Drug Discov Today. 2018;23:375\u201381.","journal-title":"Drug Discov Today"},{"key":"5058_CR142","doi-asserted-by":"publisher","first-page":"7454","DOI":"10.18632\/aging.202610","volume":"13","author":"JJ Zhuang","year":"2021","unstructured":"Zhuang JJ, Zhou L, Zheng YH, Ding YS. The serum galectin-3 levels are associated with the severity and prognosis of ischemic stroke. Aging. 2021;13:7454\u201364.","journal-title":"Aging"},{"key":"5058_CR143","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/STROKEAHA.117.019084","volume":"49","author":"A Wang","year":"2018","unstructured":"Wang A, Zhong C, Zhu Z, Xu T, Peng Y, Peng H, et al. Serum galectin-3 and poor outcomes among patients with acute ischemic stroke. Stroke. 2018;49:211\u20134.","journal-title":"Stroke"},{"key":"5058_CR144","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/ene.13496","volume":"25","author":"A Venkatraman","year":"2018","unstructured":"Venkatraman A, Hardas S, Patel N, Singh Bajaj N, Arora G, Arora P. Galectin-3: an emerging biomarker in stroke and cerebrovascular diseases. Eur J Neurol. 2018;25:238\u201346.","journal-title":"Eur J Neurol"},{"key":"5058_CR145","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jns.2016.06.071","volume":"368","author":"XJ Yan","year":"2016","unstructured":"Yan XJ, Yu GF, Jie YQ, Fan XF, Huang Q, Dai WM. Role of galectin-3 in plasma as a predictive biomarker of outcome after acute intracerebral hemorrhage. J Neurol Sci. 2016;368:121\u20137.","journal-title":"J Neurol Sci"},{"key":"5058_CR146","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000443022","volume":"41","author":"A Edsfeldt","year":"2016","unstructured":"Edsfeldt A, Bengtsson E, Asciutto G, Dun\u00e9r P, Bj\u00f6rkbacka H, Fredrikson GN, et al. High plasma levels of galectin-3 are associated with increased risk for stroke after carotid endarterectomy. Cerebrovasc Dis. 2016;41:199\u2013203.","journal-title":"Cerebrovasc Dis"},{"key":"5058_CR147","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1177\/1747493020971166","volume":"16","author":"C Hansen","year":"2021","unstructured":"Hansen C, Sastre C, Wolcott Z, Bevers MB, Kimberly WT. Time-dependent, dynamic prediction of fatty acid-binding protein 4, galectin-3, and soluble ST2 measurement with poor outcome after acute stroke. Int J Stroke. 2021;16:660\u20138.","journal-title":"Int J Stroke"},{"key":"5058_CR148","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cca.2020.09.020","volume":"511","author":"Y Liu","year":"2020","unstructured":"Liu Y, Guo D, Wang A, Yang J, Zhu Z, Xu T, et al. Combined effect of serum N-terminal pro-brain natriuretic peptide and galectin-3 on prognosis 1 year after ischemic stroke. Clin Chim Acta. 2020;511:33\u20139.","journal-title":"Clin Chim Acta"},{"key":"5058_CR149","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.04.007","volume":"28","author":"N Zeng","year":"2019","unstructured":"Zeng N, Wang A, Xu T, Zhong C, Zheng X, Zhu Z, et al. Co-effect of serum galectin-3 and high-density lipoprotein cholesterol on the prognosis of acute ischemic stroke. J Stroke Cerebrovasc Dis. 2019;28:1879\u201385.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"5058_CR150","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.arcmed.2021.01.009","volume":"52","author":"B Fenton-Navarro","year":"2021","unstructured":"Fenton-Navarro B, Gardu\u00f1o R\u00edos D, Torner L, Letechip\u00eda-Vallejo G, Cervantes M. Melatonin decreases circulating levels of galectin-3 and cytokines, motor activity, and anxiety following acute global cerebral ischemia in male rats. Arch Med Res. 2021;52:505\u201313.","journal-title":"Arch Med Res"},{"key":"5058_CR151","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1161\/STROKEAHA.118.021757","volume":"49","author":"H Nishikawa","year":"2018","unstructured":"Nishikawa H, Liu L, Nakano F, Kawakita F, Kanamaru H, Nakatsuka Y, et al. Modified citrus pectin prevents blood-brain barrier disruption in mouse subarachnoid hemorrhage by inhibiting galectin-3. Stroke. 2018;49:2743\u201351.","journal-title":"Stroke"},{"key":"5058_CR152","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-3-030-04615-6_11","volume":"127","author":"H Nishikawa","year":"2020","unstructured":"Nishikawa H, Nakano F, Liu L, Nakatsuka Y, Okada T, Shiba M, et al. The role of galectin-3 in subarachnoid hemorrhage: a preliminary study. Acta Neurochir Suppl. 2020;127:65\u201368.","journal-title":"Acta Neurochir Suppl"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05058-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05058-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05058-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T10:08:52Z","timestamp":1669284532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05058-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,20]]},"references-count":152,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["5058"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05058-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,20]]},"assertion":[{"value":"1 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"628"}}